What the Evidence Shows About Audizen
Audizen is a liquid dietary supplement marketed for tinnitus relief, but its key ingredients (including Ginkgo Biloba, Hawthorn Berry, Magnesium, Garlic Extract, and Green Tea Extract) have not been shown to reduce tinnitus in controlled clinical trials. The lead ingredient, ginkgo biloba, has been studied in 12 randomised controlled trials involving 1,915 participants, and a 2022 Cochrane systematic review found it has little to no effect on tinnitus versus placebo (Sereda et al., 2022). The AAO-HNS clinical practice guideline explicitly states that clinicians should not recommend ginkgo biloba or other dietary supplements for tinnitus (Tunkel et al., 2014).
Why So Many Tinnitus Sufferers Are Searching for Audizen
When you have been living with tinnitus for months or years, and every appointment ends with “there is no cure,” it makes complete sense to look elsewhere. Supplements feel worth trying. They are accessible, they do not require a referral, and the marketing around products like Audizen is designed to meet you exactly where your hope lives.
This article is not an affiliate review, and it is not a dismissal of your search. It is an ingredient-level evidence audit: each component of Audizen’s formula is examined against the published clinical record. You will also find a plain-language explanation of what regulatory phrases like “FDA-registered facility” actually mean in practice, and what the independent user review data looks like when you strip away the promotional noise.
If any ingredient in Audizen’s formula had meaningful clinical support, this article would say so. The evidence is what it is.
What Is Audizen? Product Overview
Audizen is sold as a liquid tinnitus supplement, taken as oral drops, and marketed under claims of auditory health support and tinnitus relief. Its stated ingredients include Ginkgo Biloba, Hawthorn Berry, Magnesium, Garlic Extract, and Green Tea Extract (EGCG). A single bottle is priced at approximately $79, with multi-bottle packages running considerably higher. One six-bottle supply has been reported at around $300. The product comes with a 60-day money-back guarantee and is available online only.
The manufacturer’s identity is not consistently disclosed. Promotional materials reference “Ideal Performance” in some listings, but this is not verified across retail channels, and the official product site offers no transparent company information. The audizen.com domain was registered in July 2025, indicating a recently launched operation (MalwareTips, 2025). BBB complaints are on file, with the majority unanswered by the manufacturer.
An independent academic review of over-the-counter tinnitus supplements found that all products surveyed made unfounded claims of relief, and that most consist of mixtures of inexpensive vitamins, minerals, and herbs sold at a premium (Vendra et al., 2019). Audizen’s ingredient combination fits this pattern precisely.
Ingredient-by-Ingredient Evidence Audit
Ginkgo Biloba
What is claimed: Audizen’s marketing implies ginkgo biloba supports auditory function and relieves tinnitus symptoms.
What the evidence shows: Ginkgo biloba is the most thoroughly studied herbal treatment for tinnitus, and the results are consistently negative. The 2022 Cochrane review analysed 12 randomised controlled trials with 1,915 participants and found that ginkgo biloba has little to no effect on tinnitus symptom severity compared to placebo (mean difference on the Tinnitus Handicap Inventory: -1.35 on a 0-100 scale, 95% CI -8.26 to 5.55) (Sereda et al., 2022). There was no significant effect on tinnitus loudness and no meaningful improvement in quality of life. A 1,121-patient trial and a separate 120mg/day RCT both found no effect, with the latter returning a non-significant p-value of 0.51.
The AAO-HNS clinical practice guideline issued a strong recommendation against ginkgo biloba: “Clinicians should not recommend Ginkgo biloba, melatonin, zinc, or other dietary supplements for treating patients with persistent, bothersome tinnitus” (Tunkel et al., 2014). This position is confirmed by the 2025 VA/DoD guideline and NICE NG155 (2020), neither of which found new evidence to change it (Sherlock et al., 2025).
Safety concern: Ginkgo biloba carries a documented, clinically significant interaction risk with anticoagulant medications including warfarin, aspirin, and clopidogrel. A systematic review of 149 articles on herbal-drug interactions documented ginkgo-warfarin interactions causing bleeding events, including fatal intracranial haemorrhage. People taking blood thinners should not use ginkgo biloba without medical supervision.
Verdict: The evidence against ginkgo biloba for tinnitus is as clear as it gets in this field. Twelve trials, nearly two thousand participants, and a Cochrane review all point in the same direction.
Hawthorn Berry
What is claimed: Included in Audizen’s formula as an ingredient with implied circulatory and auditory benefits.
What the evidence shows: According to Tinnitus UK’s April 2023 review, no papers have been published on hawthorn berry as a tinnitus treatment. There is no evidence base for this ingredient in the context of tinnitus, at any level of study design.
Verdict: Absence of evidence is not automatically evidence of absence, but when no research exists at all, no claim of benefit can be supported.
Magnesium
What is claimed: Magnesium is presented as supporting auditory pathway health.
What the evidence shows: Magnesium does have a biologically plausible role in auditory function. One small trial referenced by Tinnitus UK found a positive signal for magnesium in the context of noise-induced hearing loss prevention. This is a genuinely different condition from existing tinnitus, and the finding has not been replicated at scale. No tinnitus-specific RCTs for magnesium were identified in the research for this article.
Verdict: Biologically plausible, with a thin and indirect evidence base. People with confirmed magnesium deficiency may see some benefit from magnesium supplementation specifically, but this does not require a $79 multi-ingredient formula. A standalone magnesium supplement costs a fraction of the price.
Garlic Extract
What is claimed: Garlic extract is listed as part of the auditory support formula.
What the evidence shows: No tinnitus-specific clinical trials for garlic extract were identified in the research for this article. There is no established mechanism or clinical trial record connecting garlic supplementation to tinnitus relief.
Verdict: No evidence base exists for this ingredient in tinnitus.
Green Tea Extract (EGCG)
What is claimed: EGCG is included as an antioxidant with hearing health benefits.
What the evidence shows: Preclinical and animal data suggest that EGCG may have antioxidant-mediated protective effects against noise-induced hearing loss in a preventative context. These are animal model findings in a different condition (prevention of future hearing damage) and do not translate to a treatment for existing tinnitus. No human RCTs exist for EGCG as a treatment for existing tinnitus. Tinnitus UK has also flagged concerns about high-dose green tea extract potentially causing harm.
Verdict: The animal data is preventative, not therapeutic. It does not support a claim that EGCG treats tinnitus that already exists.
What ‘FDA-Registered Facility’ and ‘GMP-Certified’ Actually Mean
When you see “Manufactured in an FDA-Registered Facility” on a supplement label, it is easy to read that as official government endorsement. It is not.
Under the Dietary Supplement Health and Education Act of 1994 (DSHEA), supplement manufacturers are required to register their facilities with the FDA. This is an administrative notification: the manufacturer tells the FDA the facility exists. It does not mean the FDA has tested the product, reviewed the efficacy claims, or approved the supplement for any use. The FDA does not evaluate whether a dietary supplement works before it goes on sale.
“GMP-certified” refers to Good Manufacturing Practice standards, which govern manufacturing consistency and hygiene: whether the product contains what the label says it contains, in a clean environment, without contamination. This says nothing about whether the product does what the manufacturer claims it does.
As MalwareTips documented in 2025, Audizen’s “FDA-Registered Facility” language is precisely this kind of administrative label, not a product approval (MalwareTips, 2025). The distinction matters: you are being asked to pay $79 for a product whose efficacy the FDA has never reviewed.
What Real User Reviews Actually Show
Promotion for Audizen claims 49,000 five-star reviews and uses fabricated AI deepfake videos depicting celebrities including Dr. Oz, Joe Rogan, Kevin Costner, and cardiologist Dr. Dean Ornish as endorsers (MalwareTips, 2025; TinnitusTalk Forum, 2025). These endorsements are not real.
On Consumer Health Digest, an independent review platform, only 2 verified user reviews exist for Audizen, averaging 2.9 out of 5. Common themes in independent reviews include minimal symptom relief, concerns about the refund process despite the 60-day guarantee, and value-for-money dissatisfaction.
The largest population-level survey on tinnitus supplement use found that among 1,788 respondents across 53 countries, 70.7% of supplement users reported no effect on their tinnitus, 10.3% reported worsening, and only 19% reported any improvement (Coelho et al., 2016). The authors’ conclusion was direct: dietary supplements should not be recommended to treat tinnitus.
The 19% who reported improvement should not be dismissed. Tinnitus fluctuates naturally over time, and improvement that coincides with starting a supplement does not prove the supplement caused it. In tinnitus RCTs, placebo response rates typically run between 20 and 40%, meaning the Coelho improvement figure is entirely consistent with a placebo effect.
The TinnitusTalk community’s analysis also raised a mechanistic point: oral drops cannot reach the auditory cortex or the central neural circuits where tinnitus is generated. The delivery mechanism itself does not match the claimed target (TinnitusTalk Forum, 2025).
Who Might Benefit and Who Should Be Cautious
The 19% improvement figure from Coelho et al. (2016) is real, even if it is statistically indistinguishable from placebo response rates. Some people feel better while taking supplements, and that experience is valid even when the cause is uncertain.
Specific groups should exercise caution or avoid Audizen entirely:
People taking anticoagulants (warfarin, aspirin, clopidogrel) should not take ginkgo biloba without first speaking to their doctor. The bleeding risk is clinically documented and includes serious events.
People with seizure disorders should also avoid ginkgo biloba, which has documented interactions with seizure threshold.
People with confirmed magnesium deficiency may see some benefit from magnesium specifically, but a standalone supplement at a fraction of the cost addresses that need without the unnecessary additional ingredients.
Before spending $79 on a formulation with no clinical trial evidence as a combined product, speaking with an audiologist or ENT is worth the time. They can rule out treatable underlying causes and discuss options that do have evidence behind them.
Conclusion: What You Should Know Before Buying Audizen
Spending money on something that might help when you are suffering every day is completely understandable. Tinnitus is relentless, and the gap between what medicine can offer and what patients need is real and frustrating.
The evidence on Audizen’s ingredients is also real. Ginkgo biloba, the most-studied ingredient in the formula, has been evaluated in 12 randomised controlled trials and found to have little to no effect versus placebo (Sereda et al., 2022). The AAO-HNS guideline explicitly advises against it (Tunkel et al., 2014). The other ingredients have either no tinnitus-specific evidence at all or only indirect, preclinical signals that do not translate to treatment.
The two interventions with consistent support across major clinical guidelines are cognitive behavioural therapy for tinnitus distress and hearing aids for those with co-occurring hearing loss (Tunkel et al., 2014; Sherlock et al., 2025). Neither is a cure. Both have genuine evidence behind them.
If you are looking for a broader map of what the evidence actually supports, the guide to tinnitus myths and unproven cures on this site covers the full range of supplement claims and evidence-based alternatives. You deserve honest information, not a sales pitch in disguise.
